![David Kuhns](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
David Kuhns
Technik-/Wissenschafts-/F&E-Leiter bei Prosomnus Sleep Technologies, Inc.
Profil
David Kuhns has worked as the Chief Science Officer at Prosomnus Sleep Technologies, Inc. since 2016.
Aktive Positionen von David Kuhns
Unternehmen | Position | Beginn |
---|---|---|
Prosomnus Sleep Technologies, Inc.
![]() Prosomnus Sleep Technologies, Inc. Medical SpecialtiesHealth Technology Prosomnus Sleep Technologies, Inc. engages in development of a sleep device to control snore. It features the MicrO2 obstructive sleep apnea and snore device, this strategic move enables ProSomnus to treat the rapidly growing number of patients with obstructive sleep apnea (OSA). The company was founded by Len Liptak, Dave Kuhns and Sung Kim on March 1, 2017 and is headquartered in Pleasanton, CA. | Technik-/Wissenschafts-/F&E-Leiter | 01.10.2016 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Prosomnus Sleep Technologies, Inc.
![]() Prosomnus Sleep Technologies, Inc. Medical SpecialtiesHealth Technology Prosomnus Sleep Technologies, Inc. engages in development of a sleep device to control snore. It features the MicrO2 obstructive sleep apnea and snore device, this strategic move enables ProSomnus to treat the rapidly growing number of patients with obstructive sleep apnea (OSA). The company was founded by Len Liptak, Dave Kuhns and Sung Kim on March 1, 2017 and is headquartered in Pleasanton, CA. | Health Technology |